Pipeline™ Vantage Embolization Device With Shield Technology™, Medtronic – Sim&Size V1.2.6

Under Clinical Trail : The purpose of this study is to assess the safety and effectiveness of the Pipeline™ Vantage Embolization Device with Shield Technology™ in the treatment of intracranial aneurysms within the intended indication for use.

Indication for Use

The Pipeline™ Vantage Embolization Device with Shield Technology™ is intended for endovascular treatment of adults (22 years of age or older) with wide-necked intracranial aneurysms located in the internal carotid artery (up to the terminus).